{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T08:30:31Z","timestamp":1775032231187,"version":"3.50.1"},"reference-count":27,"publisher":"Informa UK Limited","issue":"15","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Bioanalysis"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.4155\/bio-2018-0064","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T16:41:52Z","timestamp":1532968912000},"page":"1181-1192","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Uplc\u2013Ms\/Ms Analysis of Keratan Sulfate From Urine Samples Collected on Filter Paper for Monitoring & Follow-Up of Morquio a Patients"],"prefix":"10.1080","volume":"10","author":[{"given":"Christiane","family":"Auray-Blais","sequence":"first","affiliation":[{"name":"Division of Medical Genetics, Department of Pediatrics, Faculty of Medicine & Health Sciences, Centre de Recherche \u2013 CIUSSS de l'Estrie-CHUS, Universit\u00e9 de Sherbrooke, 3001, 12th Avenue North, Sherbrooke, QC, CanadaJ1H 5N4"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmin","family":"Collerette-Tremblay","sequence":"additional","affiliation":[{"name":"Division of Medical Genetics, Department of Pediatrics, Faculty of Medicine & Health Sciences, Centre de Recherche \u2013 CIUSSS de l'Estrie-CHUS, Universit\u00e9 de Sherbrooke, 3001, 12th Avenue North, Sherbrooke, QC, CanadaJ1H 5N4"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Lavoie","sequence":"additional","affiliation":[{"name":"Division of Medical Genetics, Department of Pediatrics, Faculty of Medicine & Health Sciences, Centre de Recherche \u2013 CIUSSS de l'Estrie-CHUS, Universit\u00e9 de Sherbrooke, 3001, 12th Avenue North, Sherbrooke, QC, CanadaJ1H 5N4"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,7,30]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2004.01.052"},{"key":"e_1_3_3_3_1","doi-asserted-by":"crossref","unstructured":"Muenzer J . Overview of the mucopolysaccharidoses. Rheumatology (Suppl. 5) v4\u2013v12 (2011).","DOI":"10.1093\/rheumatology\/ker394"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2013.04.002"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.36833"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0634-0"},{"issue":"1","key":"e_1_3_3_7_1","first-page":"141","article-title":"Morquio A syndrome: diagnosis and current and future therapies","volume":"12","author":"Tomatsu S","year":"2014","unstructured":"Tomatsu S , YasudaE, PatelPet al. Morquio A syndrome: diagnosis and current and future therapies. Pediatr. Endocrinol. Rev.Sep ; 12 (Suppl 1), 141\u201351 (2014).","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678707.2016.1214572"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2016.11.007"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-014-0108-z"},{"issue":"3","key":"e_1_3_3_11_1","first-page":"457","article-title":"Contribution of tandem mass spectrometry to the diagnosis of lysosomal storage disorders","volume":"41","author":"Piraud M","year":"2018","unstructured":"Piraud M , PettazzoniM, LavoiePet al. Contribution of tandem mass spectrometry to the diagnosis of lysosomal storage disorders. JIMD41 (3), 457\u2013477 (2018).","journal-title":"JIMD"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.760"},{"key":"e_1_3_3_13_1","doi-asserted-by":"crossref","unstructured":"Tomatsu S Monta\u00f1oAM OgumaTet al. Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography-tandem mass spectrometry. J. Inherit. Metab. Dis. (Suppl 3) S35\u2013S42 (2010).","DOI":"10.1007\/s10545-009-9013-x"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.11.172"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.4137\/BMI.S7451"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2010.161141"},{"key":"e_1_3_3_17_1","first-page":"1","article-title":"Di-sulfated keratan sulfate as a novel biomarker for mucopolysaccharidosis II, IVA, and IVB","volume":"21","author":"Shimada T","year":"2015","unstructured":"Shimada T , TomatsuS, MasonRWet al. Di-sulfated keratan sulfate as a novel biomarker for mucopolysaccharidosis II, IVA, and IVB. JIMD Rep.21, 1\u201313 (2015).","journal-title":"JIMD Rep."},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio.15.239"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgmr.2017.04.005"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2012.01.012"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-007-0607-x"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2007.10.001"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2009.04.009"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2014.05.024"},{"key":"e_1_3_3_25_1","first-page":"17.26.1","article-title":"High-risk screening for Fabry disease: analysis by tandem mass spectrometry of globotriaosylceramide (Gb3) in urine collected on filter paper","volume":"93","author":"Auray-Blais C","year":"2017","unstructured":"Auray-Blais C , LavoieP, BoutinM, AbaouiM. High-risk screening for Fabry disease: analysis by tandem mass spectrometry of globotriaosylceramide (Gb3) in urine collected on filter paper. Curr. Protoc. Hum. Genet.93, 17.26.1\u201317.26.12 (2017).","journal-title":"Curr. Protoc. Hum. Genet."},{"key":"e_1_3_3_26_1","unstructured":"US FDA. Guidance for Industry: Analytical Procedures and Methods Validation for Drugs and Biologics (2015). https:\/\/www.fda.gov\/downloads\/drugs\/guidances\/ucm386366.pdf."},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac203433e"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/8904_2016_1"}],"container-title":["Bioanalysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/bio-2018-0064","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T19:28:35Z","timestamp":1715974115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/bio-2018-0064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,30]]},"references-count":27,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["10.4155\/bio-2018-0064"],"URL":"https:\/\/doi.org\/10.4155\/bio-2018-0064","relation":{},"ISSN":["1757-6180","1757-6199"],"issn-type":[{"value":"1757-6180","type":"print"},{"value":"1757-6199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-03-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}